Nobel laureate David Baker launches $95M AI biology lab betting against the 'virtual cell'
TheMoonMidas · x · 2026-09-11
Nobel laureate David Baker has launched AI BioDesign, a $95M AI biology lab backed by the Allen Institute, UW, and Fred Hutch, taking a contrarian bet on AI in biology.
- Instead of chasing a single general "virtual cell" model, the lab will build a suite of specialized models for specific design problems: cancer therapies, plastic-dissolving enzymes, and cells that navigate the body.
- Everything will be published open and free — the director says it's fine if a company takes the free data and builds a profitable drug.
A notable public route-bet in AI x biology worth tracking.
More from Venture
- Indie Dev Pivots NoSpoon to Private Tool, Citing No Future for Consumer AI — Kyrannio · 2026-09-11
- Mechanize reportedly acquihired by Google for over $1.5 billion — JacquesThibs · 2026-09-11
- Investor calls out Jevons Paradox misuse: better AI models don't guarantee AI stocks rise — citrini · 2026-09-11
- Selling outcomes, not robots: why hardware offers no refuge from commodification — JohnnyNi13 · 2026-09-11
- In a world of VC ads and AI SEO, creative is the indie founder's best moat — alexmacgregor__ · 2026-09-11
- The New Moats: 5 Advantages AI Can't Compress — brucemacv · 2026-09-11